Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00818415 · ClinicalTrials.gov registry record · Phase 1
Naproxen Sodium ER Pharmacokinetic Study
A Phase 1 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT00818415 is a Phase 1 study that has completed, run by Bayer. The registered enrollment target is 32 participants.
The verdict
NCT00818415, a Phase 1 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
To determine the pharmacokinetic profile of the investigational product following dosing under fed conditions.
Interventions
- DRUG Naproxen sodium ER (BAYH6689)
- DRUG Commercial Naproxen (Aleve, BAYH6689)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-11 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00818415
The ClinicalTrials.gov registry entry for NCT00818415 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Naproxen sodium ER (BAYH6689) is the first listed.
NCT00818415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00818415 about?
NCT00818415 is a clinical study titled "Naproxen Sodium ER Pharmacokinetic Study". To determine the pharmacokinetic profile of the investigational product following dosing under fed conditions.
What is the current status of trial NCT00818415?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2008-11. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00818415?
The interventions under investigation include: Naproxen sodium ER (BAYH6689) (DRUG), Commercial Naproxen (Aleve, BAYH6689) (DRUG).
Who is sponsoring clinical trial NCT00818415?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.